Metformin May Offer Similar Benefits as Exercise

• A standard diabetes drug might mimic one key impact of train in these with prostate most cancers.
• Researchers discovered metformin boosts an “train molecule” linked to urge for food and weight management, even in these unable to remain lively.
• Whereas not an alternative choice to train, the drug might assist people handle treatment-related weight acquire and metabolic well being.

Common train is related to a variety of well being advantages, together with a reduced risk of most cancers.

Bodily exercise can also be essential through the therapy of sure cancers, similar to prostate cancer, the place therapy itself might result in weight acquire or different metabolic dysfunction.

Scientists beforehand recognized an exercise-induced molecule — referred to as N-lactoyl-phenylalanine (Lac-Phe), a compound launched throughout bodily exercise — related to weight reduction and decreased urge for food, and it seems to be stimulated by metformin, a diabetes drug.

In an exploratory examine, researchers discovered that prostate most cancers sufferers handled with metformin had Lac-Phe ranges similar to these seen after strenuous train. The findings had been printed on April 6 within the journal EMBO Molecular Medicine.

Researchers initially identified Lac-Phe, a molecule produced throughout train, in wholesome folks and athletes, together with ultramarathon runners, and later discovered elevated levels in folks with diabetes handled with metformin.

“Altered metabolism is likely one of the hallmarks of most cancers. So, what would occur with most cancers sufferers handled with metformin?” stated first examine writer Marijo Bilusic, MD, PhD, a genitourinary medical oncologist at Sylvester Complete Most cancers Middle.

“In our examine, we had been very stunned to see that the extent of Lac-Phe in our prostate most cancers sufferers was precisely the identical as the extent of ultramarathoners. This has by no means been reported earlier than,” he informed Healthline.

Whereas metformin didn’t predict improved therapy response, similar to PSA levels or tumor progress, it was related to improved weight administration, together with amongst sufferers prescribed anti-androgen therapy, which is linked with weight acquire.

S. Adam Ramin, MD, board licensed urologist, urologic oncologist, and medical director of Urology Most cancers Specialists in Los Angeles, CA, who wasn’t concerned within the analysis, known as it “an intriguing preliminary examine,” however cautioned that bigger research could be essential to validate the findings.

Bilusic and his group analyzed blood samples from males with prostate most cancers enrolled in a scientific trial known as BIMET-1, together with an extra group of people handled at a most cancers heart.

Within the trial, 12 sufferers with chubby or obesity (however not diabetes) had been studied intimately out of 29 initially enrolled within the cohort. Members had been randomly assigned to obtain both normal care alone or metformin at a dose of 1,000 mg twice every day, adopted by mixture therapy with the hormone remedy drug bicalutamide.

To substantiate their findings, the researchers additionally studied an extra 25 people with prostate most cancers throughout a spread of illness phases, together with superior most cancers. Of those, seven had been taking metformin. Throughout each teams, the group measured Lac-Phe ranges and in contrast them earlier than and after therapy.

The researchers discovered that metformin constantly elevated ranges of Lac-Phe in prostate most cancers, no matter most cancers stage, physique weight, or different remedies. Within the scientific trial group, Lac-Phe ranges rose considerably after metformin therapy. Within the broader participant group, these taking metformin clearly had greater ranges than those that weren’t. The will increase reached ranges just like these seen after intense train.

Importantly, folks taking metformin additionally confirmed higher weight management throughout hormone remedy, which is understood to trigger weight acquire. Within the trial, practically all people on metformin prevented weight acquire over a number of months of therapy, whereas these not taking it had been extra prone to acquire weight. Though not conclusive, researchers consider this can be linked to ranges of Lac-Phe within the physique, that are related to diminished urge for food and meals consumption.

Whereas Lac-Phe is assumed to behave on the mind to suppress urge for food, the way it does so stays unclear. And better Lac-Phe ranges didn’t predict whether or not an individual’s most cancers responded to therapy. The examine builds on the findings of the STAMPEDE trial, a significant potential trial printed in 2025 that discovered that metformin improved weight administration and lowered glucose ranges in sufferers with prostate most cancers, however confirmed no proof of improved survival.

“We all know that males on hormone remedy, similar to oral anti-androgen remedy, have a tendency to achieve weight, develop weight problems, and metabolic syndrome. Metformin might show to be efficient in stopping these issues,” stated Ramin.

However, he added, “At this level, it’s untimely to suggest metformin to sufferers with prostate most cancers on hormone remedy.”

The significance of exercise after a prostate most cancers analysis can’t be overstated.

Analysis means that staying bodily lively is related to a roughly one-third reduction in cancer-related mortality and practically a one-half discount in all-cause mortality.

It’s too early to foretell the position metformin and, by extension, Lac-Phe may play in supporting prostate most cancers therapy, however the findings are intriguing.

As a result of folks with prostate most cancers are typically older, they might be much less prone to have interaction in common bodily exercise. A pharmacological intervention that would assist fill that hole would signify a significant addition to present therapy choices.

Nevertheless, Bilusic cautioned that metformin just isn’t an “train tablet.”

Train impacts quite a few methods within the physique, together with muscular tissues, the cardiovascular system, neurotransmitters, and bones.

Metformin doesn’t act on the physique in the identical manner, nor does it have the identical spectrum of results. However in a single particular pathway, growing Lac-Phe, it seems to be significant.

“There are numerous different features of the train that Metformin might be not changing,” Bilusic stated. “However for some sufferers, they will’t train as a result of they’re in ache, [or] most cancers remedy is making them fatigued. They’re gaining weight. So, how can we reverse that? Taking a tablet a day, that’s simpler than working for a half hour within the health club.”